# PULSE BIOSCIENCES, INC. (PLSE) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from PULSE BIOSCIENCES, INC.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/PLSE/mda/fy2025/): filed 2026-02-19; accession 0001437749-26-004724 (https://www.sec.gov/Archives/edgar/data/1625101/000143774926004724/plse20251231_10k.htm); latest 10-K
- [FY 2024 MD&A](/company/PLSE/mda/fy2024/): filed 2025-03-31; accession 0001437749-25-009932 (https://www.sec.gov/Archives/edgar/data/1625101/000143774925009932/plse20241231_10k.htm)
- [FY 2023 MD&A](/company/PLSE/mda/fy2023/): filed 2024-03-28; accession 0001437749-24-009815 (https://www.sec.gov/Archives/edgar/data/1625101/000143774924009815/plse20231231_10k.htm)
- [FY 2022 MD&A](/company/PLSE/mda/fy2022/): filed 2023-03-31; accession 0001437749-23-008846 (https://www.sec.gov/Archives/edgar/data/1625101/000143774923008846/plse20221231_10k.htm)
- [FY 2021 MD&A](/company/PLSE/mda/fy2021/): filed 2022-03-31; accession 0001625101-22-000016 (https://www.sec.gov/Archives/edgar/data/1625101/000162510122000016/plse-20211231x10k.htm)

Back to /company/PLSE/